Utah Medical Products
UTMD
72 hedge funds and large institutions have $242M invested in Utah Medical Products in 2021 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 24 increasing their positions, 24 reducing their positions, and 2 closing their positions.
200% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 2
9% more capital invested
Capital invested by funds: $221M → $242M (+$20.4M)
6% more funds holding
Funds holding: 68 → 72 (+4)
0.06% more ownership
Funds ownership: 71.22% → 71.28% (+0.06%)
0% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 24
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HP
HealthInvest Partners
Stockholm,
Sweden
|
+$3.71M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.89M |
| 3 |
Wells Fargo
San Francisco,
California
|
+$552K |
| 4 |
RIM
Ranger Investment Management
Dallas,
Texas
|
+$434K |
| 5 |
MAM
Martingale Asset Management
Boston,
Massachusetts
|
+$319K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$3.46M |
| 2 |
Renaissance Technologies
New York
|
-$1.23M |
| 3 |
BlackRock
New York
|
-$758K |
| 4 |
Russell Investments Group
London,
United Kingdom
|
-$515K |
| 5 |
LCM
Legato Capital Management
San Francisco,
California
|
-$473K |
UTMD Hedge Fund Activity: Q3 2021 in Review
72 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in Utah Medical Products (UTMD) for Q3 2021, worth a combined $242M — up 9.2% from $221M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new UTMD positions and 2 closed out — a net gain of 4 holders — while 24 added to existing stakes and 24 trimmed.
The largest buyer was HealthInvest Partners, opening a new position worth an estimated $3.71M. The largest seller was Fidelity Investments, cutting an estimated $3.46M.
- 72 institutional investors held Utah Medical Products (UTMD) as of Q3 2021, up from 68 in Q2 2021.
- Funds reported $242M of Utah Medical Products stock for Q3 2021, up 9.2% quarter-over-quarter.
- 6 funds opened new Utah Medical Products positions in Q3 2021 and 2 closed out, a net change of +4 holders.
- The largest Utah Medical Products buyer in Q3 2021 was HealthInvest Partners, an estimated $3.71M added.
- The largest Utah Medical Products seller in Q3 2021 was Fidelity Investments, an estimated $3.46M sold.
Based on aggregated 13F filings for Q3 2021.